| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers V > Headlines for Vantage Oncology, Inc. > News item |
S&P assigns B to Vantage Oncology notes
Standard & Poor's said it assigned its B issue-level rating to Vantage Oncology Holdings LLC's proposed $250 million senior secured notes, with a 3 recovery rating. The 3 recovery rating indicates an expectation for meaningful (50%-70%) recovery in the event of a payment default.
In addition, with the removal of financial maintenance covenants, S&P said it is revising its liquidity descriptor to "adequate" from "less than adequate." The B corporate credit rating and stable outlook are unchanged.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.